Loop diuretics in chronic heart failure: how to manage congestion?
- PMID: 30194516
- DOI: 10.1007/s10741-018-9735-7
Loop diuretics in chronic heart failure: how to manage congestion?
Abstract
Loop diuretics remain the cornerstone of congestion management in contemporary chronic heart failure care. However, their use is not supported by high quality data, and there is doubt about the safety in the outpatient heart failure setting. Still, congestion is related to a worse outcome, and there is general consensus among experts that congestion should not be tolerated in heart failure patients. Recommendations in international guidelines, regarding decongestion strategies in chronic heart failure, are limited. Thus, there is an emerging need for clinical decision-making support about the best strategy for using loop diuretics and decongestion in the chronic setting. The present review provides a comprehensive overview over the evidence of chronic loop diuretic use. Strategies for the assessment of congestion in the outpatient setting and decongestion algorithm are provided to assist health care specialists in delivering high-quality heart failure care.
Keywords: Chronic heart failure; Decongestion; Diuretic resistance; Diuretic therapy; Loop diuretic; Volume overload.
Similar articles
-
Loop diuretics in heart failure.Heart Fail Rev. 2012 Mar;17(2):305-11. doi: 10.1007/s10741-011-9245-3. Heart Fail Rev. 2012. PMID: 21516306 Review.
-
Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.JACC Heart Fail. 2016 Jan;4(1):1-8. doi: 10.1016/j.jchf.2015.06.017. Epub 2015 Dec 2. JACC Heart Fail. 2016. PMID: 26656139
-
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.Clin Res Cardiol. 2021 Aug;110(8):1221-1233. doi: 10.1007/s00392-020-01779-7. Epub 2020 Nov 20. Clin Res Cardiol. 2021. PMID: 33216179
-
Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.Curr Heart Fail Rep. 2022 Feb;19(1):15-25. doi: 10.1007/s11897-021-00538-7. Epub 2022 Jan 17. Curr Heart Fail Rep. 2022. PMID: 35037162 Review.
-
Combinational Diuretics in Heart Failure.Curr Heart Fail Rep. 2024 Aug;21(4):1-11. doi: 10.1007/s11897-024-00659-9. Epub 2024 Apr 9. Curr Heart Fail Rep. 2024. PMID: 38589570 Review.
Cited by
-
The Importance of Venous Reflux Status Evaluation in the Intensive Care Unit.Aging Dis. 2024 May 7;15(3):953-964. doi: 10.14336/AD.2023.0731. Aging Dis. 2024. PMID: 37611903 Free PMC article. Review.
-
Effectiveness and safety of chronic diuretic use in older adults: an umbrella review of recently published systematic reviews and meta-analyses of randomized-controlled trials.Eur Geriatr Med. 2025 May 25. doi: 10.1007/s41999-025-01229-5. Online ahead of print. Eur Geriatr Med. 2025. PMID: 40413712 Review.
-
Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure.Exp Ther Med. 2019 Sep;18(3):1639-1644. doi: 10.3892/etm.2019.7730. Epub 2019 Jul 3. Exp Ther Med. 2019. PMID: 31410120 Free PMC article.
-
Soluble CD146-an underreported novel biomarker of congestion: a comment on a review concerning congestion assessment and evaluation in acute heart failure.Heart Fail Rev. 2021 May;26(3):731-732. doi: 10.1007/s10741-020-09950-y. Heart Fail Rev. 2021. PMID: 32372227 Review.
-
Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review.Eur Geriatr Med. 2023 Aug;14(4):659-674. doi: 10.1007/s41999-023-00752-7. Epub 2023 Feb 3. Eur Geriatr Med. 2023. PMID: 36732414 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical